Skip to main content
. 2021 Dec 30;8(1):e000805. doi: 10.1136/bmjgast-2021-000805

Table 4.

Comparisons between participants with and without insomnia symptoms and preliminary evidence of efficacy of CBT-I based on actigraphy data

No insomnia (N=9)
Mean (SE)
Pre-CBT-I (N=8)
Mean (SE)
Insomnia vs no insomnia
t test and effect size (95% CI)
1-month follow-up (N=7) Insomnia pretreatment vs post-treatment T test and effect size (95% CI)
Wake after sleep onset in minutes 59.47 (10.58) 117.78 (23.99) t(15)=2.32, p=0.035; 1.07 (0.07 to 2.03) 61.84 (11.83) t(6)=4.13, p=0.006; 1.46 (0.38 to 2.50)
Hours of sleep 6.59 (.24) 7.16 (.29) t(15)=1.51, p=0.15; 0.70 (−0.25 to 1.62) 6.52 (0.31) t(6)=5.79, p=0.001; 2.05 (0.70 to 3.35)
Sleep efficiency (%) 86.5% (2.45) 78.6% (3.55) t(15)=−1.87, p=0.08; −0.86 (−1.81 to 0.10) 86.3% (2.24) t(6)=−2.64, p=0.039; 0.93 (0.05 to 1.77)

Bolded values are significant though should be interpreted with caution given our small sample size.

CBT-I, cognitive–behavioural therapy for insomnia.